Brief: Black Diamond Therapeutics Reports Quarterly Loss Of $0.60 Per Share

Black Diamond Therapeutics

08/11/2022 13:00

Nov 8 (Reuters) - Black Diamond Therapeutics Inc
 BDTX.O :
    * BLACK DIAMOND THERAPEUTICS- CASH, CASH EQUIVALENTS &
INVESTMENTS
OF $144.2 MILLION AT QUARTER END EXPECTED TO BE SUFFICIENT TO
FUND OPERATIONS INTO Q3 2024
    * QTRLY LOSS PER SHARE $0.60
    * Q3 EARNINGS PER SHARE VIEW $-0.64 -- REFINITIV IBES DATA

Source text for Eikon:  ID: 
Further company coverage:  BDTX.O 
 ((Reuters.Briefs@thomsonreuters.com;))